Durham, NC (PRWEB) March 10, 2014
Experts from Cato BioVentures are attending BIO Europe Spring this week in Turin, Italy. This global event for life science companies brings together top executives from all industry segments around the world, ready to meet and build strategic partnerships in the life science sector. These industry segments include biotech and pharmaceutical companies, private investors, and other life science service companies.
The conference includes high-caliber partnering opportunities, networking, company presentations, panels, and informative workshops featuring corporate leaders who share insight and advice. Over 1,300 companies attended last year, showcasing the latest technologies, products, and services during the BIO Europe Spring conference.
The following Cato BioVentures experts will attend:
- Lynda Sutton, B.Sc., Principal and Cofounder
- Jo Cato, Ph.D., Vice President
- Heschi Rotmensch, M.D., F.A.C.C., F.A.C.P., Medical Analyst
- David Gee, B.Sc. (Hons), Strategic Business Developer
These experts will participate in networking events and attend one-on-one partnering sessions while at the conference.
For more information, call 919-361-2286, e-mail info(at)cato(dot)com, or visit Cato BioVentures online at http://www.CatoBioVentures.com.
About Cato BioVentures
Cato BioVentures is the venture capital affiliate of Cato Research, a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepreneurs, academic institutions, and a broad base of biotechnology and pharmaceutical companies to advance a robust portfolio of successful product development programs. Through strategic CRO service agreements with Cato Research, Cato BioVentures has invested its CRO Service Capital™ in innovative therapeutics, medical devices, and stem cell technologies that improve the pharmaceutical industry’s research and development productivity. If strategic outsourcing for development, regulatory, and clinical support is a core component of a company’s business plan, then Cato BioVenture’s investment model can make a positive difference in the company’s overall success. For more information about Cato BioVentures, call 919-361-2286 or visit http://www.CatoBioVentures.com.
About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 250 and offices located in the United States, Europe, Canada, Israel, and South Africa, the Cato Research team consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing their clients’ products to market with speed and cost-effectiveness. For more information about Cato Research, visit http://www.Cato.com.
# # #